Editorial · 22 Feb 2013
Conference abstractPublished 28 Nov 2013
Pregabalin: Use, misuse and abuse
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pregabalin is a prescription drug approved for the treatment of generalized anxiety disorder; partial epilepsy; peripheral and central neuropathic pain; and has been recently approved by the FDA for the treatment of fibromyalgia. It has also been studied in clinical trials for its potential as a replacement therapy for alcohol and benzodiazepine addiction. Pregabalin is an alpha-2-delta ligand, structurally related to the neurotransmitter GABA. Similar to other compounds modulating GABA-ergic neurotransmission (e.g. benzodiazepines), there is some concern about its potential to cause addiction. However, the results of premarketing trials have been conflicting in this respect and thus pregabalin has been classified as a Schedule V drug by the US Drug Enforcement Administration, indicating that it has low abuse potential. Following the rapidly increasing use of pregabalin, data signaling its abuse liability have been published recently. Currently, these data are limited to two cross-over randomized control trials, one database analysis, one analysis of anecdotal online reports and a few case reports. Aim of the presentation is to highlight the potential for abuse of pregabalin, especially in patients with a history of substance-seeking behavior. Considering that the drug has recently been proposed as a treatment for substance misuse, namely for both alcohol and benzodiazepine-dependent individuals, a better clarification of its abuse potential is essential in order to characterize its extent and nature.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 27 Aug 2024
Understanding Drug Abuse and Misuse: A Critical Public Health Issue
Commentary · 26 Jul 2022
Drug Misuse, Abuse and Addiction of Non-Prescription Medication in Older Adults
Perspective · 25 Jan 2022
A Brief Study on Drug Misuse, Abuse, and Addiction
Short communication · 1 Aug 2020
Pharmacovigilance 2020: The Pharmacoepidemiological aspect of psychoactive prescription containing drug of abuse and misuse in sub Saharan Africa- Abubakar Mukhtar- Sharda University
More from this journal
The newest in Clinical Pharmacology & Biopharmaceutics.
Research article · 27 Jul 2026
Qualitative LC/MS Assessment of Fenfluramine Hydrochloride After Dilution in Purified Water : A Preliminary Study and Case Report
Article · 20 Jul 2026
Population Pharmacology: Precision Dosing for Diverse Patients
Article · 17 Jul 2026
Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Georgios Papazisis”
